Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Alnylam Pharmaceuticals Revenue 2010-2024 | ALNY

Alnylam Pharmaceuticals annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Alnylam Pharmaceuticals revenue for the quarter ending June 30, 2024 was $0.660B, a 107% increase year-over-year.
  • Alnylam Pharmaceuticals revenue for the twelve months ending June 30, 2024 was $2.344B, a 89.46% increase year-over-year.
  • Alnylam Pharmaceuticals annual revenue for 2023 was $1.828B, a 76.23% increase from 2022.
  • Alnylam Pharmaceuticals annual revenue for 2022 was $1.037B, a 22.88% increase from 2021.
  • Alnylam Pharmaceuticals annual revenue for 2021 was $0.844B, a 71.31% increase from 2020.
  
Alnylam Pharmaceuticals Annual Revenue
(Millions of US $)
2023 $1,828
2022 $1,037
2021 $844
2020 $493
2019 $220
2018 $75
2017 $90
2016 $47
2015 $41
2014 $51
2013 $47
2012 $67
2011 $83
2010 $100
2009 $101
Alnylam Pharmaceuticals Quarterly Revenue
(Millions of US $)
2024-06-30 $660
2024-03-31 $494
2023-12-31 $440
2023-09-30 $751
2023-06-30 $319
2023-03-31 $319
2022-12-31 $335
2022-09-30 $264
2022-06-30 $225
2022-03-31 $213
2021-12-31 $259
2021-09-30 $188
2021-06-30 $221
2021-03-31 $178
2020-12-31 $164
2020-09-30 $126
2020-06-30 $104
2020-03-31 $99
2019-12-31 $72
2019-09-30 $70
2019-06-30 $45
2019-03-31 $33
2018-12-31 $21
2018-09-30 $2
2018-06-30 $30
2018-03-31 $22
2017-12-31 $38
2017-09-30 $17
2017-06-30 $16
2017-03-31 $19
2016-12-31 $17
2016-09-30 $14
2016-06-30 $9
2016-03-31 $7
2015-12-31 $8
2015-09-30 $6
2015-06-30 $9
2015-03-31 $19
2014-12-31 $24
2014-09-30 $11
2014-06-30 $7
2014-03-31 $8
2013-12-31 $11
2013-09-30 $9
2013-06-30 $9
2013-03-31 $19
2012-12-31 $8
2012-09-30 $17
2012-06-30 $21
2012-03-31 $21
2011-12-31 $20
2011-09-30 $21
2011-06-30 $21
2011-03-31 $21
2010-12-31 $21
2010-09-30 $28
2010-06-30 $27
2010-03-31 $25
2009-12-31 $27
2009-09-30 $24
2009-06-30 $25
2009-03-31 $25
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $38.097B $1.828B
Alnylam Pharmaceuticals Inc. is a development-stage biopharmaceutical company focused on the development of novel therapeutics based on RNA interference. The company's pipeline of experimental RNAi therapeutics is focused across three strategic therapeutic areas - genetic medicines, cardio-metabolic disease and hepatic infectious disease. The company's lead drug-Onpattro received regulatory approvals in the United States and Europe for the treatment of hereditary transthyretin-mediated amyloidosis in adults. The FDA approved Givlaari for acute hepatic porphyria. The FDA approved Oxlumo injection for subcutaneous use, for the treatment of primary hyperoxaluria type 1 to lower urinary oxalate levels in pediatric and adult patients. Moreover, the company is evaluating inclisiran for hypercholesterolemia in partnership with The Medicines Company acquired by Novartis. The FDA approved Leqvio to reduce low-density lipoprotein cholesterol with two doses a year..
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $172.660B 17.28
Vertex Pharmaceuticals (VRTX) United States $128.723B 0.00
Regeneron Pharmaceuticals (REGN) United States $110.039B 25.98
Gilead Sciences (GILD) United States $108.763B 18.59
Bristol Myers Squibb (BMY) United States $107.817B 38.82
CSL (CSLLY) Australia $97.519B 0.00
GSK (GSK) United Kingdom $80.746B 9.37
Argenex SE (ARGX) Netherlands $32.520B 0.00
Biogen (BIIB) United States $27.610B 11.66
BioNTech SE (BNTX) Germany $27.217B 0.00
Illumina (ILMN) United States $22.863B 156.00
Moderna (MRNA) United States $21.073B 0.00
BeiGene (BGNE) Cayman Islands $20.674B 0.00
Genmab (GMAB) Denmark $15.194B 18.98
BioMarin Pharmaceutical (BMRN) United States $13.191B 39.03
Vaxcyte (PCVX) United States $12.903B 0.00
Incyte (INCY) United States $12.794B 830.38
Exact Sciences (EXAS) United States $12.792B 0.00
Insmed (INSM) United States $12.763B 0.00
Sarepta Therapeutics (SRPT) United States $11.849B 270.11
Bio-Techne Corp (TECH) United States $11.129B 43.57
QIAGEN (QGEN) Netherlands $9.742B 20.57
Bio-Rad Laboratories (BIO.B) United States $9.332B 30.92
Roivant Sciences (ROIV) United Kingdom $8.808B 0.00
Revolution Medicines (RVMD) United States $8.352B 0.00
Intra-Cellular Therapies (ITCI) United States $8.314B 0.00
Exelixis (EXEL) United States $8.289B 25.49
Repligen (RGEN) United States $7.961B 121.49
Legend Biotech (LEGN) United States $7.856B 0.00
Ascendis Pharma (ASND) Denmark $7.681B 0.00
Viking Therapeutics (VKTX) United States $7.159B 0.00
Halozyme Therapeutics (HALO) United States $6.623B 17.43
Nuvalent (NUVL) United States $6.620B 0.00
Cytokinetics (CYTK) United States $6.416B 0.00
Zealand Pharma (ZLDPF) Denmark $5.890B 0.00
Blueprint Medicines (BPMC) United States $5.448B 0.00
Avidity Biosciences (RNA) United States $5.328B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.232B 0.00
Arcellx (ACLX) United States $5.121B 0.00
Krystal Biotech (KRYS) United States $5.080B 340.04
Biohaven (BHVN) United States $4.882B 0.00
Alkermes (ALKS) Ireland $4.665B 16.38
Axsome Therapeutics (AXSM) United States $4.434B 0.00
Immunovant (IMVT) United States $4.283B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.107B 0.00
Denali Therapeutics (DNLI) United States $3.926B 0.00
ADMA Biologics Inc (ADMA) United States $3.757B 62.00
Amicus Therapeutics (FOLD) United States $3.550B 0.00
Merus (MRUS) Netherlands $3.529B 0.00
Apellis Pharmaceuticals (APLS) United States $3.400B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.385B 0.00
Edgewise Therapeutics (EWTX) United States $3.330B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.281B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.120B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.072B 0.00
Kymera Therapeutics (KYMR) United States $2.856B 0.00
Iovance Biotherapeutics (IOVA) United States $2.846B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.816B 0.00
Protagonist Therapeutics (PTGX) United States $2.770B 17.95
Neumora Therapeutics (NMRA) United States $2.714B 0.00
Twist Bioscience (TWST) United States $2.667B 0.00
Zai Lab (ZLAB) China $2.626B 0.00
Janux Therapeutics (JANX) United States $2.598B 0.00
IDEAYA Biosciences (IDYA) United States $2.593B 0.00
Guardant Health (GH) United States $2.544B 0.00
Apogee Therapeutics (APGE) United States $2.530B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.516B 84.28
Bavarian Nordic (BVNRY) Denmark $2.516B 13.47
CG Oncology (CGON) United States $2.466B 0.00
Geron (GERN) United States $2.447B 0.00
ImmunityBio (IBRX) United States $2.396B 0.00
Scholar Rock Holding (SRRK) United States $2.341B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.302B 0.00
Keros Therapeutics (KROS) United States $2.292B 0.00
SpringWorks Therapeutics (SWTX) United States $2.286B 0.00
Structure Therapeutics (GPCR) United States $2.266B 0.00
Vera Therapeutics (VERA) United States $2.187B 0.00
Akero Therapeutics (AKRO) United States $2.140B 0.00
Intellia Therapeutics (NTLA) United States $2.131B 0.00
Myriad Genetics (MYGN) United States $2.119B 0.00
Beam Therapeutics (BEAM) United States $2.007B 0.00
Vericel (VCEL) United States $1.994B 0.00
Galapagos (GLPG) Belgium $1.993B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.988B 17.93
Ligand Pharmaceuticals (LGND) United States $1.935B 32.88
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.906B 0.00
Celldex Therapeutics (CLDX) United States $1.905B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.876B 0.00
Certara (CERT) United States $1.861B 60.90
Arvinas (ARVN) United States $1.856B 0.00
NovoCure (NVCR) Jersey $1.829B 0.00
WAVE Life Sciences (WVE) Singapore $1.822B 0.00
MannKind (MNKD) United States $1.815B 66.00
Nurix Therapeutics (NRIX) United States $1.751B 0.00
Fortrea Holdings (FTRE) United States $1.738B 53.89
NeoGenomics (NEO) United States $1.730B 0.00
Belite Bio (BLTE) United States $1.714B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.693B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.688B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.677B 0.00
Spyre Therapeutics (SYRE) United States $1.668B 0.00
Arcus Biosciences (RCUS) United States $1.668B 0.00
Novavax (NVAX) United States $1.657B 0.00
Viridian Therapeutics (VRDN) United States $1.550B 0.00
Disc Medicine (IRON) United States $1.501B 0.00
Dynavax Technologies (DVAX) United States $1.431B 99.27
Tarsus Pharmaceuticals (TARS) United States $1.410B 0.00
Travere Therapeutics (TVTX) United States $1.396B 0.00
Kura Oncology (KURA) United States $1.386B 0.00
Tyra Biosciences (TYRA) United States $1.372B 0.00
Praxis Precision Medicines (PRAX) United States $1.330B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.323B 0.00
Gyre Therapeutics (GYRE) United States $1.310B 0.00
Cogent Biosciences (COGT) United States $1.274B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.270B 0.00
ANI Pharmaceuticals (ANIP) United States $1.265B 17.18
Autolus Therapeutics (AUTL) United Kingdom $1.251B 0.00
Immatics (IMTX) Germany $1.140B 0.00
Mesoblast (MESO) Australia $1.134B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.109B 0.00
Bicara Therapeutics (BCAX) United States $1.058B 0.00
Vir Biotechnology (VIR) United States $1.055B 0.00
Rapport Therapeutics (RAPP) United States $1.026B 0.00
Cullinan Therapeutics (CGEM) United States $1.007B 0.00
CARGO Therapeutics (CRGX) United States $0.996B 0.00
Applied Therapeutics (APLT) United States $0.991B 0.00
ArriVent BioPharma (AVBP) United States $0.974B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.968B 0.00
AnaptysBio (ANAB) United States $0.965B 0.00
Zymeworks (ZYME) United States $0.957B 0.00
IGM Biosciences (IGMS) United States $0.951B 0.00
Prothena (PRTA) Ireland $0.917B 0.00
Castle Biosciences (CSTL) United States $0.913B 0.00
Sana Biotechnology (SANA) United States $0.903B 0.00
Pliant Therapeutics (PLRX) United States $0.892B 0.00
Liquidia Technologies (LQDA) United States $0.880B 0.00
MiMedx (MDXG) United States $0.856B 24.29
Zenas BioPharma (ZBIO) United States $0.854B 0.00
Dianthus Therapeutics (DNTH) United States $0.823B 0.00
89BIO (ETNB) United States $0.808B 0.00
Annexon (ANNX) United States $0.806B 0.00
Erasca (ERAS) United States $0.791B 0.00
AbCellera Biologics (ABCL) Canada $0.790B 0.00
BioAge Labs (BIOA) United States $0.786B 0.00
Pacira BioSciences (PCRX) United States $0.782B 7.40
Arbutus Biopharma (ABUS) United States $0.778B 0.00
Replimune (REPL) United States $0.773B 0.00
Tango Therapeutics (TNGX) United States $0.750B 0.00
MBX Biosciences (MBX) United States $0.738B 0.00
Immunome (IMNM) United States $0.726B 0.00
LENZ Therapeutics (LENZ) United States $0.724B 0.00
Olema Pharmaceuticals (OLMA) United States $0.705B 0.00
Stoke Therapeutics (STOK) United States $0.699B 0.00
Mineralys Therapeutics (MLYS) United States $0.690B 0.00
Neurogene (NGNE) United States $0.688B 0.00
Adaptive Biotechnologies (ADPT) United States $0.684B 0.00
Cytek Biosciences (CTKB) United States $0.676B 0.00
Astria Therapeutics (ATXS) United States $0.664B 0.00
Entrada Therapeutics (TRDA) United States $0.656B 5.96
Abivax SA (ABVX) France $0.655B 0.00
Avid Bioservices (CDMO) United States $0.648B 0.00
ACELYRIN, INC (SLRN) United States $0.647B 0.00
Oric Pharmaceuticals (ORIC) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.633B 0.00
CureVac (CVAC) Germany $0.631B 0.00
CorMedix Inc (CRMD) United States $0.606B 0.00
Nuvation Bio (NUVB) United States $0.606B 0.00
Q32 Bio (QTTB) United States $0.599B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.597B 0.00
Pharming Group (PHAR) Netherlands $0.584B 0.00
Humacyte (HUMA) United States $0.580B 0.00
Oculis Holding AG (OCS) Switzerland $0.574B 0.00
Celcuity (CELC) United States $0.572B 0.00
Allogene Therapeutics (ALLO) United States $0.563B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.555B 0.00
Revance Therapeutics (RVNC) United States $0.543B 0.00
Third Harmonic Bio (THRD) United States $0.539B 0.00
Tectonic Therapeutic (TECX) United States $0.529B 0.00
Terns Pharmaceuticals (TERN) United States $0.528B 0.00
Alumis (ALMS) United States $0.525B 0.00
REGENXBIO (RGNX) United States $0.524B 0.00
Aura Biosciences (AURA) United States $0.510B 0.00
Alector (ALEC) United States $0.501B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.495B 0.00
Emergent Biosolutions (EBS) United States $0.484B 0.00
PureTech Health (PRTC) United States $0.482B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.474B 0.00
Anavex Life Sciences (AVXL) United States $0.467B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.466B 0.00
Cartesian Therapeutics (RNAC) United States $0.464B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.463B 0.00
Absci (ABSI) United States $0.457B 0.00
Prime Medicine (PRME) United States $0.456B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.451B 0.00
C4 Therapeutics (CCCC) United States $0.444B 0.00
GRAIL (GRAL) United States $0.441B 0.00
Voyager Therapeutics (VYGR) United States $0.437B 28.61
Foghorn Therapeutics (FHTX) United States $0.428B 0.00
Contineum Therapeutics (CTNM) United States $0.424B 0.00
GH Research (GHRS) Ireland $0.416B 0.00
Biomea Fusion (BMEA) United States $0.414B 0.00
EnGene Holdings (ENGN) Canada $0.411B 0.00
MaxCyte (MXCT) United States $0.399B 0.00
MeiraGTx Holdings (MGTX) United States $0.386B 0.00
Alto Neuroscience (ANRO) United States $0.385B 0.00
Northwest Biotherapeutics (NWBO) United States $0.382B 0.00
Anika Therapeutics (ANIK) United States $0.372B 179.64
ProQR Therapeutics (PRQR) Netherlands $0.367B 0.00
Fate Therapeutics (FATE) United States $0.367B 0.00
Nautilus Biotechnology (NAUT) United States $0.360B 0.00
ITeos Therapeutics (ITOS) United States $0.351B 0.00
Design Therapeutics (DSGN) United States $0.341B 0.00
XOMA Royalty (XOMA) United States $0.338B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.337B 0.00
Alpha Teknova (TKNO) United States $0.334B 0.00
Zura Bio (ZURA) United States $0.329B 0.00
Climb Bio (CLYM) United States $0.326B 0.00
Inozyme Pharma (INZY) United States $0.323B 0.00
AC Immune (ACIU) Switzerland $0.318B 0.00
GENFIT S.A (GNFT) France $0.316B 0.00
Atea Pharmaceuticals (AVIR) United States $0.315B 0.00
Artiva Biotherapeutics (ARTV) United States $0.310B 0.00
UniQure (QURE) Netherlands $0.306B 0.00
Kamada (KMDA) Israel $0.305B 19.63
Sutro Biopharma (STRO) United States $0.304B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.304B 0.00
Urogen Pharma (URGN) United States $0.301B 0.00
Jasper Therapeutics (JSPR) United States $0.300B 0.00
Opthea (OPT) Australia $0.294B 0.00
Abeona Therapeutics (ABEO) United States $0.292B 0.00
Prima BioMed (IMMP) Australia $0.289B 0.00
PepGen (PEPG) United States $0.289B 0.00
Nkarta (NKTX) United States $0.282B 0.00
TScan Therapeutics (TCRX) United States $0.279B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.276B 0.00
Editas Medicine (EDIT) United States $0.273B 0.00
Ocugen (OCGN) United States $0.268B 0.00
Rezolute (RZLT) United States $0.265B 0.00
Compass Therapeutics (CMPX) United States $0.262B 0.00
ChromaDex (CDXC) United States $0.261B 0.00
Mersana Therapeutics (MRSN) United States $0.259B 0.00
Instil Bio (TIL) United States $0.257B 0.00
2seventy Bio (TSVT) United States $0.256B 0.00
Poseida Therapeutics (PSTX) United States $0.247B 0.00
Solid Biosciences (SLDB) United States $0.244B 0.00
Kyverna Therapeutics (KYTX) United States $0.244B 0.00
Codexis (CDXS) United States $0.239B 0.00
Cabaletta Bio (CABA) United States $0.237B 0.00
Semper Paratus Acquisition (TVGN) United States $0.235B 0.00
Amarin (AMRN) Ireland $0.234B 0.00
Inhibrx Biosciences (INBX) United States $0.234B 0.00
Precigen (PGEN) United States $0.231B 0.00
XBiotech (XBIT) United States $0.230B 0.00
Trevi Therapeutics (TRVI) United States $0.226B 0.00
Fulcrum Therapeutics (FULC) United States $0.222B 0.00
ScPharmaceuticals (SCPH) United States $0.220B 0.00
Gossamer Bio (GOSS) United States $0.218B 0.00
Eton Pharmaceuticals (ETON) United States $0.217B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.215B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.213B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.205B 0.00
BioStem Technologies (BSEM) $0.204B 32.03
ATyr Pharma (ATYR) United States $0.201B 0.00
Sangamo Therapeutics (SGMO) United States $0.195B 0.00
Candel Therapeutics (CADL) United States $0.188B 0.00
Greenwich LifeSciences (GLSI) United States $0.187B 0.00
DiaMedica Therapeutics (DMAC) United States $0.183B 0.00
Molecular Partners AG (MOLN) Switzerland $0.183B 0.00
Black Diamond Therapeutics (BDTX) United States $0.182B 0.00
Scilex Holding (SCLX) United States $0.182B 0.00
Caribou Biosciences (CRBU) United States $0.175B 0.00
Kodiak Sciences (KOD) United States $0.174B 0.00
Ventyx Biosciences (VTYX) United States $0.173B 0.00
Tenaya Therapeutics (TNYA) United States $0.170B 0.00
Adverum Biotechnologies (ADVM) United States $0.168B 0.00
Sagimet Biosciences (SGMT) United States $0.166B 0.00
Innate Pharma S.A (IPHA) France $0.163B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.160B 0.00
Vigil Neuroscience (VIGL) United States $0.158B 0.00
Lifecore Biomedical (LFCR) United States $0.156B 0.00
Compugen (CGEN) Israel $0.154B 0.00
Generation Bio (GBIO) United States $0.154B 0.00
Akoya Biosciences (AKYA) United States $0.151B 0.00
Inovio Pharmaceuticals (INO) United States $0.147B 0.00
Actuate Therapeutics (ACTU) United States $0.145B 0.00
Seres Therapeutics (MCRB) United States $0.144B 0.00
Immunic (IMUX) United States $0.143B 0.00
Repare Therapeutics (RPTX) Canada $0.142B 0.00
Rani Therapeutics Holdings (RANI) United States $0.140B 0.00
Puma Biotechnology (PBYI) United States $0.139B 14.90
Checkpoint Therapeutics (CKPT) United States $0.134B 0.00
I-Mab (IMAB) China $0.130B 0.00
Cardiff Oncology (CRDF) United States $0.130B 0.00
Skye Bioscience (SKYE) United States $0.128B 0.00
Adherex Technologies (FENC) United States $0.128B 116.25
Inventiva S.A (IVA) France $0.127B 0.00
Nuvectis Pharma (NVCT) United States $0.126B 0.00
Invivyd (IVVD) United States $0.125B 0.00
Coya Therapeutics (COYA) United States $0.125B 0.00
Elutia (ELUT) United States $0.122B 0.00
Adicet Bio (ACET) United States $0.122B 0.00
Oncobiologics (OTLK) United States $0.122B 0.00
23andMe Holding (ME) United States $0.120B 0.00
Seer (SEER) United States $0.119B 0.00
Benitec Biopharma (BNTC) United States $0.118B 0.00
FibroBiologics (FBLG) United States $0.117B 0.00
Renovaro (RENB) United States $0.116B 0.00
PDS Biotechnology (PDSB) United States $0.114B 0.00
Annovis Bio (ANVS) United States $0.113B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.111B 0.00
Verastem (VSTM) United States $0.107B 0.00
Adagene (ADAG) China $0.107B 0.00
Cellectis S.A (CLLS) France $0.106B 0.00
Genenta Science S.p.A (GNTA) Italy $0.105B 0.00
INmune Bio (INMB) United States $0.099B 0.00
Oncolytics Biotech (ONCY) Canada $0.099B 0.00
Agenus (AGEN) United States $0.099B 0.00
Coherus BioSciences (CHRS) United States $0.098B 0.00
Genelux (GNLX) United States $0.097B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.096B 0.00
Bright Minds Biosciences (DRUG) United States $0.096B 0.00
Bluebird Bio (BLUE) United States $0.094B 0.00
BeyondSpring (BYSI) United States $0.093B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.092B 0.00
InflaRx (IFRX) Germany $0.091B 0.00
CytomX Therapeutics (CTMX) United States $0.091B 8.29
Werewolf Therapeutics (HOWL) United States $0.090B 0.00
BioAtla (BCAB) United States $0.089B 0.00
MediciNova (MNOV) United States $0.089B 0.00
CervoMed (CRVO) United States $0.087B 0.00
Clearside Biomedical (CLSD) United States $0.086B 0.00
X4 Pharmaceuticals (XFOR) United States $0.084B 0.00
Ovid Therapeutics (OVID) United States $0.083B 0.00
BioHarvest Sciences (CNVCF) Canada $0.083B 0.00
VistaGen Therapeutics (VTGN) United States $0.083B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
IO Biotech (IOBT) Denmark $0.080B 0.00
ALX Oncology Holdings (ALXO) United States $0.080B 0.00
Cidara Therapeutics (CDTX) United States $0.078B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.078B 0.00
Aileron Therapeutics (ALRN) United States $0.078B 0.00
Chimerix (CMRX) United States $0.078B 0.00
Adlai Nortye (ANL) Cayman Islands $0.072B 0.00
DBV Technologies S.A (DBVT) France $0.069B 0.00
Spero Therapeutics (SPRO) United States $0.069B 3.13
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
Connect Biopharma Holdings (CNTB) United States $0.069B 0.00
Boundless Bio (BOLD) United States $0.067B 0.00
Aerovate Therapeutics (AVTE) United States $0.067B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.067B 0.00
Shattuck Labs (STTK) United States $0.066B 0.00
Entera Bio (ENTX) Israel $0.065B 0.00
Precision BioSciences (DTIL) United States $0.065B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.064B 0.00
Immuneering (IMRX) United States $0.062B 0.00
TELA Bio (TELA) United States $0.062B 0.00
Leap Therapeutics (LPTX) United States $0.060B 0.00
Kezar Life Sciences (KZR) United States $0.060B 0.00
Rapt Therapeutics (RAPT) United States $0.059B 0.00
Theratechnologies (THTX) Canada $0.059B 0.00
Imunon (IMNN) United States $0.059B 0.00
Enzo Biochem (ENZ) United States $0.058B 0.00
Allakos (ALLK) United States $0.058B 0.00
Omega Therapeutics (OMGA) United States $0.057B 0.00
Celularity (CELU) United States $0.057B 0.00
Kronos Bio (KRON) United States $0.056B 0.00
Cue Biopharma (CUE) United States $0.054B 0.00
Aadi Bioscience (AADI) United States $0.053B 0.00
Syros Pharmaceuticals (SYRS) United States $0.052B 0.00
Elicio Therapeutics (ELTX) United States $0.051B 0.00
Affimed (AFMD) Germany $0.050B 0.00
HOOKIPA Pharma (HOOK) United States $0.050B 0.00
Vor Biopharma (VOR) $0.049B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.049B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.047B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.047B 0.00
Immix Biopharma (IMMX) United States $0.046B 0.00
Atara Biotherapeutics (ATRA) United States $0.046B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.046B 0.00
Rallybio (RLYB) United States $0.045B 0.00
Lexaria Bioscience (LEXX) Canada $0.045B 0.00
Intensity Therapeutics (INTS) United States $0.044B 0.00
CalciMedica (CALC) United States $0.043B 0.00
Fortress Biotech (FBIO) United States $0.041B 0.00
VTv Therapeutics (VTVT) United States $0.041B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.041B 0.00
NextCure (NXTC) United States $0.041B 0.00
Equillium (EQ) United States $0.038B 0.00
Passage Bio (PASG) United States $0.037B 0.00
Clene (CLNN) United States $0.037B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Ocean Biomedical (OCEA) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Quince Therapeutics (QNCX) United States $0.034B 0.00
OKYO Pharma (OKYO) $0.034B 0.00
Dyadic (DYAI) United States $0.033B 0.00
Ocuphire Pharma (OCUP) United States $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.033B 0.00
Elevation Oncology (ELEV) United States $0.033B 0.00
Eyenovia (EYEN) United States $0.033B 0.00
Curis (CRIS) United States $0.032B 0.00
Longeveron (LGVN) United States $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
LakeShore Biopharma (LSB) China $0.031B 0.00
Dare Bioscience (DARE) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Lumos Pharma (LUMO) United States $0.031B 0.00
Estrella Immunopharma (ESLA) United States $0.030B 0.00
BRIACELL THERAP (BCTX) Canada $0.030B 0.00
BioAffinity Technologies (BIAF) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Femasys (FEMY) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.027B 0.00
MiNK Therapeutics (INKT) United States $0.027B 0.00
Pluri (PLUR) Israel $0.026B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.026B 0.00
SAB Biotherapeutics (SABS) United States $0.025B 0.00
NKGen Biotech (NKGN) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Bolt Biotherapeutics (BOLT) United States $0.024B 0.00
Aprea Therapeutics (APRE) United States $0.024B 0.00
RenovoRx (RNXT) United States $0.024B 0.00
KALA BIO (KALA) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
UNITY Biotechnology (UBX) United States $0.023B 0.00
BioXcel Therapeutics (BTAI) United States $0.023B 0.00
Aligos Therapeutics (ALGS) United States $0.023B 0.00
Cyclo Therapeutics (CYTH) United States $0.023B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
HCW Biologics (HCWB) United States $0.021B 0.00
Spruce Biosciences (SPRB) United States $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.021B 0.00
Biora Therapeutics (BIOR) United States $0.020B 0.00
Monopar Therapeutics (MNPR) United States $0.020B 0.00
Chemomab Therapeutics (CMMB) Israel $0.018B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
Cadrenal Therapeutics (CVKD) United States $0.017B 0.00
Athira Pharma (ATHA) United States $0.017B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Orgenesis (ORGS) United States $0.015B 0.00
Evaxion Biotech (EVAX) Denmark $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Cara Therapeutics (CARA) United States $0.015B 0.00
Aytu BioPharma (AYTU) United States $0.014B 0.00
Novogen (KZIA) Australia $0.014B 0.00
COSCIENS Biopharma (CSCI) Canada $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
Tenax Therapeutics (TENX) United States $0.013B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.013B 0.00
Kintara Therapeutics (KTRA) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Vincerx Pharma (VINC) United States $0.011B 0.00
Apollomics (APLM) United States $0.011B 0.00
IN8bio (INAB) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Carmell (CTCX) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Portage Biotech (PRTG) $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Gritstone Bio (GRTS) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
NuCana (NCNA) United Kingdom $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
180 Life Sciences (ATNF) United States $0.004B 0.00
Dogwood Therapeutics (DWTX) United States $0.004B 0.00
Vaccinex (VCNX) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Biofrontera (BFRI) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Notable Labs (NTBL) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Invo BioScience (INVO) United States $0.004B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Elevai Labs (ELAB) United States $0.002B 0.00
Ensysce Biosciences (ENSC) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
GRI Bio (GRI) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
GENPREX (GNPX) United States $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00